Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03931317 · ClinicalTrials.gov registry record · NA
Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT03931317 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 70 participants.
The verdict
NCT03931317, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare the effect of Latanoprostene Bunod and Timolol on eye pressure and blood vessels of the back of the eye.
Interventions
- DRUG Latanoprostene bunod 0.024% QD
- DRUG Timolol maleate 0.5% BID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-12-03 |
| Est. Completion | 2023-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03931317
The ClinicalTrials.gov registry entry for NCT03931317 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Latanoprostene bunod 0.024% QD is the first listed.
NCT03931317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03931317 about?
NCT03931317 is a clinical study titled "Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity". The purpose of this research study is to compare the effect of Latanoprostene Bunod and Timolol on eye pressure and blood vessels of the back of the eye.
What is the current status of trial NCT03931317?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2018-12-03. Estimated completion is 2023-03-01.
What interventions are being tested in trial NCT03931317?
The interventions under investigation include: Latanoprostene bunod 0.024% QD (DRUG), Timolol maleate 0.5% BID (DRUG).
Who is sponsoring clinical trial NCT03931317?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.